Cumberland Pharmaceuticals Inc.
CPIX
$6.29
-$0.33-4.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -361.68% | 25.85% | -25.69% | -- |
| Total Depreciation and Amortization | -- | 18.58% | -25.51% | -5.58% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -39.68% | 129.57% | 99.51% | -- |
| Change in Net Operating Assets | -- | 77.03% | -101.25% | -39.26% | -- |
| Cash from Operations | -- | -90.07% | -99.84% | -60.63% | 198.61% |
| Capital Expenditure | -- | -- | 100.00% | -54.55% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 94.82% | -12,444.08% | -425.37% | -- |
| Cash from Investing | -- | 95.02% | -11,367.54% | -464.35% | 710.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 75.19% | 100.00% | 89.47% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -37.41% | -46.73% | 14.06% | -- |
| Cash from Financing | -- | 86.19% | 50.54% | 27.92% | 51.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 84.68% | -851.32% | -794.08% | 180.77% |